Related Experiment Videos
[Initial Groningen experiences with dynamic cardiomyoplasty]
M P van den Berg1, M H Brouwer, D S Wijnberg
1Academisch Ziekenhuis, Thoraxcentrum, Groningen.
Insights
Cardiomyoplasty offers heart failure symptom relief but carries a risk of sudden death from ventricular arrhythmias. Further research is needed to prevent fatal arrhythmias and improve patient outcomes.
Area of Science:
- Cardiology
- Cardiac Surgery
Background:
- Heart failure management remains a significant clinical challenge.
- Medically refractory heart failure often requires advanced surgical interventions.
Observation:
- Four patients with refractory heart failure underwent cardiomyoplasty.
- The surgical procedure and post-operative training were uneventful.
Findings:
- One patient showed no improvement in heart failure symptoms.
- Three patients experienced significant symptom relief post-cardiomyoplasty.
- All three patients who improved died suddenly within one year, likely due to ventricular arrhythmias.
Implications:
- Cardiomyoplasty shows potential for heart failure treatment.
- Preventing sudden cardiac death is crucial for the success of cardiomyoplasty.
- Investigating implantable cardioverter-defibrillators may mitigate mortality risk.
Abstract:
Four patients, one woman and three men aged 48, 62, 49, en 54 years respectively, were subjected to cardiomyoplasty because of medically refractory heart failure secondary to ischaemic or idiopathic dilating cardiomyopathy. The operation and the training period were uncomplicated. In one patient symptoms of heart failure did not improve; the other patients experienced substantial relief of symptoms. However, all three died suddenly within one year after the operation, probably due to ventricular arrhythmias. Cardiomyoplasty may deserve a place in the treatment of heart failure, provided sudden death can be better prevented. Possibly, treatment with an implantable cardioverter-defibrillator might be useful.